3-iodobenzylguanidine has been researched along with Cerebrovascular Disorders in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, YY; Chung, YA; Kim, HT; Kim, J; Kim, JS; Kim, SH; Kim, YI; Lee, KS; Lee, PH; Park, JW | 1 |
| Ito, R; Narita, T; Ohno, M; Shimada, M; Takano, T; Yamano, T | 1 |
2 other study(ies) available for 3-iodobenzylguanidine and Cerebrovascular Disorders
| Article | Year |
|---|---|
Cardiac [123I]metaiodobenzylguanidine scintigraphy for vascular Parkinsonism.
Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Case-Control Studies; Cerebrovascular Disorders; Female; Heart; Humans; Male; Middle Aged; Parkinsonian Disorders; Radionuclide Imaging; Radiopharmaceuticals | 2006 |
Hypertension in Leigh syndrome--a case report.
Topics: 3-Iodobenzylguanidine; Adrenal Glands; Brain; Cerebrovascular Disorders; Child; Child, Preschool; Fatal Outcome; Female; Humans; Hypertension; Infant; Kidney; Leigh Disease; Magnetic Resonance Imaging; Medulla Oblongata; Tomography, Emission-Computed; Ultrasonography | 1998 |